Home/All Molecules/Lumefantrine

Lumefantrine Range

Comprehensive Lumefantrine portfolio for Franchise & Manufacturing.

Category
lumefantrine
Total Formulations
5
Available Forms
Dry Syrup, Tablets

Expand Your Business with Our Multiple Divisions


Browse Lumefantrine portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Lumefantrine batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Lumefantrine PCD Pharma Franchise Company

Lumefantrine PCD Pharma Franchise Company

Cafoli Lifecare is a trusted Lumefantrine PCD pharma franchise company offering 5 WHO-GMP certified Lumefantrine formulations. We provide district-wise monopoly rights, quality-assured products and complete promotional support to pharma distributors, franchise partners and marketing professionals across India.

What is Lumefantrine?

Lumefantrine is a long-acting blood schizonticide antimalarial that, usually combined with artemether, kills the malaria parasite in its blood stage. It is used to treat uncomplicated Plasmodium falciparum malaria. Reference data is available on PubChem.

Available Lumefantrine Formulations

Our Lumefantrine portfolio spans 5 formulations available in Dry Syrup and Tablet forms. This range lets franchise partners serve multiple prescriber and patient segments from a single dependable supplier, with consistent quality across every batch.

Therapeutic Applications

Lumefantrine, given as an artemether-lumefantrine combination, is used to treat acute, uncomplicated falciparum malaria in adults and children. It is prescribed by general physicians and paediatricians and is important in malaria-endemic regions.

Why Lumefantrine is a High-Potential Molecule for Distributors

Malaria remains endemic across many Indian states, and artemisinin-based combinations like artemether-lumefantrine are first-line therapy, giving Lumefantrine dependable seasonal and regional demand. Distributors in endemic zones can serve retail and institutional channels with tablet and dry-syrup options for adults and children.

Why Choose Cafoli Lifecare

As a WHO-GMP certified and DCGI-approved pharma company, Cafoli Lifecare gives franchise partners district-wise monopoly rights, quality-assured products, attractive margins and complete promotional inputs including visual aids, product cards and marketing support. With a network of 1000+ partners across India, we combine dependable supply with genuine on-ground support to help you grow.

References

  1. PubChem - Lumefantrine
  2. PubMed - Lumefantrine clinical literature

Aceclofenac in Modern Clinical Practice

Our formulations of Lumefantrine find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Lumefantrine in PCD Franchise

Start Your Lumefantrine Franchise with Cafoli Lifecare

Ready to launch your Lumefantrine PCD pharma franchise with monopoly rights and full promotional support? Call +91 95184 47302 or email info@cafoli.in to get started.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 5 WHO-GMP certified Lumefantrine formulations across dry syrup and tablet forms for malaria treatment.

Yes. We grant district-wise monopoly rights so each franchise partner markets Lumefantrine exclusively within their allotted territory.

Lumefantrine, as part of an artemether-lumefantrine combination, is prescribed by general physicians and paediatricians treating falciparum malaria.

Lumefantrine is best absorbed when taken with a fat-containing meal, and the full combination course must be completed for effective cure. It is a prescription-only antimalarial and should be used only as directed.

A valid Drug License and GST registration are required to appoint a Lumefantrine PCD franchise with Cafoli Lifecare.